Prevalence of anxiety and depression in pulmonary hypertension and changes during therapy

Respiration

Volumn 91, Issue 5, 2016, Pages 359-366

  Somaini, Gina ^a   Hasler, Elisabeth D ^a   Saxer, Stéphanie ^a   Huber, Lars C ^a   Lichtblau, Mona ^a   Speich, Rudolf ^a   Bloch, Konrad E ^a   Ulrich, Silvia ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Anxiety and depression; Chronic thromboembolic pulmonary hypertension; Health related quality of life; Pulmonary arterial hypertension; Pulmonary hypertension

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; GUANYLATE CYCLASE ACTIVATOR; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID; PROSTAGLANDIN;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CAMBRIDGE PULMONARY HYPERTENSION OUTCOME QUESTIONNAIRE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FUNCTIONAL ASSESSMENT; HEMODYNAMICS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; SIX MINUTE WALK DISTANCE TEST; ANXIETY; ANXIETY DISORDERS; CHRONIC DISEASE; COMPLICATION; DEPRESSIVE DISORDER; ENDARTERECTOMY; HYPERTENSION, PULMONARY; MIDDLE AGED; PSYCHOLOGY; PULMONARY ARTERY; PULMONARY EMBOLISM; WALK TEST;

AGED; ANXIETY; ANXIETY DISORDERS; CHRONIC DISEASE; DEPRESSION; DEPRESSIVE DISORDER; ENDARTERECTOMY; ENDOTHELIN RECEPTOR ANTAGONISTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PREVALENCE; PROSTAGLANDINS; PULMONARY ARTERY; PULMONARY EMBOLISM; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; WALK TEST;

EID: 84970021206     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000445805     Document Type: Article

References (34)

1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(12 suppl S):5S-12S.
2. Jamieson SW, Madani M: Chronic thromboembolic pulmonary hypertension. Ann Vasc Dis 2009; 2: 133-135.
3. Mayer E, Klepetko W: Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006; 3: 589-593.
4. Cheli M, Vachiery JL: Controversies in pulmonary hypertension due to left heart disease. F1000Prime Rep 2015; 7: 07.
5. Nathan SD, Hassoun PM: Pulmonary hypertension due to lung disease and/or hypoxia. Clin Chest Med 2013; 34: 695-705.
6. Strange G, Gabbay E, Kermeen F, Williams T, Carrington M, Stewart S, Keogh A: Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study. Pulm Circ 2013; 3: 89-94.
7. Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ: Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: Results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 2012; 186: 790-796.
8. Wryobeck JM, Lippo G, McLaughlin V, Riba M, Rubenfire M: Psychosocial aspects of pulmonary hypertension: A review. Psychosomatics 2007; 48: 467-475.
9. Harzheim D, Klose H, Pinado FP, Ehlken N, Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth HJ, Halank M, Mayer E, Grunig E, Guth S: Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res 2013; 14: 104.
10. Lowe B, Grafe K, Ufer C, Kroenke K, Grunig E, Herzog W, Borst MM: Anxiety and depression in patients with pulmonary hypertension. Psychosom Med 2004; 66: 831-836.
11. McCollister DH, Beutz M, McLaughlin V, Rumsfeld J, Masoudi FA, Tripputi M, Yaeger T, Weintraub P, Badesch DB: Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status. Psychosomatics 2010; 51: 339- 339.e8.
12. White J, Hopkins RO, Glissmeyer EW, Kitterman N, Elliott CG: Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res 2006; 7: 55.
13. Vanhoof JMM, Delcroix M, Vandevelde E, Denhaerynck K, Wuyts W, Belge C, Dobbels F: Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J Heart Lung Transplant 2014; 33: 800- 808.
14. Batal O, Khatib OF, Bair N, Aboussouan LS, Minai OA: Sleep quality, depression, and quality of life in patients with pulmonary hypertension. Lung 2011; 189: 141-149.
15. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD: Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137: 376-387.
16. Taichman DB, Shin J, Hud L, Archer-Chicko C, Kaplan S, Sager JS, Gallop R, Christie J, Hansen-Flaschen J, Palevsky H: Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 2005; 6: 92.
17. Mueller-Mottet S, Stricker H, Domenighetti G, Azzola A, Geiser T, Schwerzmann M, Weilenmann D, Schoch O, Fellrath JM, Rochat T, Lador F, Beghetti M, Nicod L, Aubert JD, Popov V, Speich R, Keusch S, Hasler E, Huber LC, Grendelmeier P, Tamm M, Ulrich S: Long-term data from the Swiss pulmonary hypertension registry. Respiration 2015; 89: 127-140.
18. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62(25 suppl):D34-D41.
19. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
20. Nowak C, Sievi NA, Clarenbach CF, Schwarz EI, Schlatzer C, Brack T, Brutsche M, Frey M, Irani S, Leuppi JD, Rudiger J, Thurnheer R, Kohler M: Accuracy of the Hospital Anxiety and Depression Scale for identifying depression in chronic obstructive pulmonary disease patients. Pulm Med 2014; 2014: 973858.
21. Shafazand S, Goldstein MK, Doyle RL, Hlatky MA, Gould MK: Health-related quality of life in patients with pulmonary arterial hypertension. Chest 2004; 126: 1452-1459.
22. Halank M, Speich R, Petkova D, Saxer S, Muller-Mottet S, Hasler E, Kolditz M, Wilkens H, Ehlken N, Lichtblau M, Egenlauf B, Kahler C, Luneburg N, Mertens D, Schulz U, Barner A, Grunig E, Puhan M, Ulrich S: Quality of life in pulmonal arterial hypertension and in chronic thromboembolic pulmonary hypertension (in German). Dtsch Med Wochenschr 2014; 139(suppl 4):S126-S135.
23. Cenedese E, Speich R, Dorschner L, Ulrich S, Maggiorini M, Jenni R, Fischler M: Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 2006; 28: 808-815.
24. Cima K, Twiss J, Speich R, McKenna SP, Grunig E, Kahler CM, Ehlken N, Treder U, Crawford SR, Huber LC, Ulrich S: The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). Health Qual Life Outcomes 2012; 10: 110.
25. McCollister DH: Screening pulmonary hypertension patients for depression. Int J Clin Pract Suppl 2011; 174: 4-5.
26. Larisch A, Neeb C, de Zwaan M, Pabst C, Tiede H, Ghofrani A, Olsson K, Hoeper M, Kruse J: Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension (in German). Psychother Psychosom Med Psychol 2014; 64: 384-389.
27. Breeman S, Cotton S, Fielding S, Jones GT: Normative data for the Hospital Anxiety and Depression Scale. Qual Life Res 2015; 24: 391- 398.
28. Hinz A, Brahler E: Normative values for the Hospital Anxiety and Depression Scale (HADS) in the general German population. J Psychosom Res 2011; 71: 74-78.
29. Simonneau G, Galie N, Jansa P, Meyer GM, Al-Hiti H, Kusic-Pajic A, Lemarie JC, Hoeper MM, Rubin LJ: Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients. Int J Cardiol 2014; 172: 332-339.
30. Said K: Macitentan in pulmonary arterial hypertension: The SERAPHIN trial. Glob Cardiol Sci Pract 2014; 2014: 26-30.
31. Rival G, Lacasse Y, Martin S, Bonnet S, Provencher S: Effect of pulmonary arterial hypertension- specific therapies on health-related quality of life: A systematic review. Chest 2014; 146: 686-708.
32. Tartavoulle TM: A predictive model of the effects of depression, anxiety, stress, 6-minutewalk distance, and social support on healthrelated quality of life in an adult pulmonary hypertension population. Clin Nurse Spec 2015; 29: 22-28.
33. Kingman M, Hinzmann B, Sweet O, Vachiery JL: Living with pulmonary hypertension: unique insights from an international ethnographic study. BMJ Open 2014; 4:e004735.
34. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-119.